Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Slavin

Showing results (141-150 of 436) with videos related to

Pageof 44
Sort By:
The Journal of Experimental Medicine|July 1, 1977
Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin graftsS Slavin, S Strober, Z Fuks, et al.
Bone Marrow Transplantation|September 1, 1989
The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z)S Slavin, M Mumcuoglu, A Landesberg-Weisz, et al.
Experimental Hematology|January 1, 1993
Continuous intravenous administration of rmGM-CSF enhances immune as well as hematopoietic reconstitution following syngeneic bone marrow transplantation in miceE Naparstek, M Ohana, J S Greenberger, et al.
Bone Marrow Transplantation|March 1, 1991
The effect of total or partial T lymphocyte depletion on susceptibility to influenza virus infection and development of antiviral immunity in lethally irradiated mice reconstituted with immune syngeneic bone marrow graftsM Mumcuoglu, Z Zakay-Rones, L Weiss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1983
Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantationL Weiss, S Morecki, E S Vitetta, et al.
Experimental Hematology|March 25, 1999
Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: comparison of T-cell and IL-2 activated killer (LAK) cell-mediated adoptive immunotherapy in murine modelsU Vourka-Karussis, A Ackerstein, T Pugatsch, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|January 1, 1996
A model smoking-intervention curriculum for medical schoolR P Usatine, M Wilkes, S Slavin, et al.
Cell Transplantation|November 1, 1996
Successful treatment of diabetes in NOD mice with advanced disease by islet isografts following immunoregulation with Linomide (quinoline-3-carboxamide)S Slavin, L Weiss, W Xia, et al.
Clinical and Experimental Immunology|June 1, 1995
Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblastsA Nagler, V Segal, S Slavin, et al.
Transplantation|May 27, 1997
Permanent and specific transplantation tolerance induced by a nonmyeloablative treatment to a wide variety of allogeneic tissues: I. Induction of tolerance by a short course of total lymphoid irradiation and selective elimination of the donor-specific host lymphocytesT B Prigozhina, O Gurevitch, J Zhu, et al.
Pageof 44

Showing results (141-150 of 436) with videos related to

Sort By:
Pageof 44
The Journal of Experimental Medicine|July 1, 1977
Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin graftsS Slavin, S Strober, Z Fuks, et al.
Bone Marrow Transplantation|September 1, 1989
The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z)S Slavin, M Mumcuoglu, A Landesberg-Weisz, et al.
Experimental Hematology|January 1, 1993
Continuous intravenous administration of rmGM-CSF enhances immune as well as hematopoietic reconstitution following syngeneic bone marrow transplantation in miceE Naparstek, M Ohana, J S Greenberger, et al.
Bone Marrow Transplantation|March 1, 1991
The effect of total or partial T lymphocyte depletion on susceptibility to influenza virus infection and development of antiviral immunity in lethally irradiated mice reconstituted with immune syngeneic bone marrow graftsM Mumcuoglu, Z Zakay-Rones, L Weiss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1983
Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantationL Weiss, S Morecki, E S Vitetta, et al.
Experimental Hematology|March 25, 1999
Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: comparison of T-cell and IL-2 activated killer (LAK) cell-mediated adoptive immunotherapy in murine modelsU Vourka-Karussis, A Ackerstein, T Pugatsch, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|January 1, 1996
A model smoking-intervention curriculum for medical schoolR P Usatine, M Wilkes, S Slavin, et al.
Cell Transplantation|November 1, 1996
Successful treatment of diabetes in NOD mice with advanced disease by islet isografts following immunoregulation with Linomide (quinoline-3-carboxamide)S Slavin, L Weiss, W Xia, et al.
Clinical and Experimental Immunology|June 1, 1995
Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblastsA Nagler, V Segal, S Slavin, et al.
Transplantation|May 27, 1997
Permanent and specific transplantation tolerance induced by a nonmyeloablative treatment to a wide variety of allogeneic tissues: I. Induction of tolerance by a short course of total lymphoid irradiation and selective elimination of the donor-specific host lymphocytesT B Prigozhina, O Gurevitch, J Zhu, et al.
Pageof 44